Sub Banner Image

Why Is Precigen Stock Surging On Friday?

Market Impact

Vandana Singh

·

August 15, 2025

·

Benzinga

Precigen's Papzimeos wins FDA approval as the first therapy for adult recurrent respiratory papillomatosis, showing durable results in clinical trials.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.